20 May 2013
Keywords: bioxell, gets, further, rights, bxl, italy, purchased
Article | 05 July 2004
Italy's BioXell has purchased additional indications from Swiss drugmajor Roche for BXL 628 which, under the original deal, was licensed to
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 July 2004
12 July 2004
17 May 2013
© 2013 thepharmaletter.com